I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Stroke is a kind of acute cerebrovascular disease characterized by high morbidity, disability and death rates. It is reported that stroke has become one of the most frequently-occurring neurological injuries in USA and China, about 800,000 and 2,000,000 people every year respectively (Roger et al., 2011). Stroke includes ischemic stroke and hemorrhagic stroke, and a large number of clinical studies and animal experiments have shown that the cerebral injury and ischemia-reperfusion injury caused by stroke are complex physiopathologic processes, involving toxic effects of excitatory amino acids, inflammatory reaction, oxidative stress, the generation of free radical, brain edema, neuronal apoptosis/death (Zhu et al., 2015). Although the mechanisms of the injury are diverse, our treatment theory of neuroprotective strategies mainly focus on two aspects: on the one hand, we can activate the endogenous protective mechanisms of patients' bodies to protect the brain from injury; on the other hand, it is advisable to try our best to minimize secondary brain injury and promote the recovery of the damaged tissues. For many years, people have been trying to understand and search effective treatments for stroke from every conceivable angle. For now, for ischemic stroke, thrombolytic and anticoagulant therapy has become regular treatments (Mandava et al., 2015), and for hemorrhagic stroke, hematomas cleaning operation and the stable control of intracranial pressure are conductive to improve the prognosis of patients (Siler et al., 2014). In addition, hypothermia has been considered to be a valuable clinical treatment for centuries (Thome et al., 2005), and mild hypothermia (33-36°C) has been demonstrated to play neuroprotective role (Antonic et al., 2014; Wang et al., 2014). Its mechanisms mainly involve decreasing the metabolism rates of brain tissues and alleviating brain edema (Hobbs et al., 2008). Besides, a variety of methods are used for the treatment of stroke, including stroke unit, neuronal electrophysiological treatment, and even the possibility of psychological therapy (Pohjasvaara et al., 1998; Patel et al., 2004; Sheffler and Chae, 2007). Our previous studies suggested that pramipexole-induced hypothermia could effectively inhibit subarachnoid hemorrhage-induced early brain injury in rats *via* phosphoinositide 3-kinase/protein kinase B/glycogen synthase kinase-3 signaling pathway (Ma et al., 2016). However, the present theories for stroke are still unsatisfactory and needed to be further improved, although the development of evidence-based medicine is ongoing. Specifically, in recent years, medical gas, including oxygen and hydrogen, have become issues of concern. No matter ischemic stroke or hemorrhagic stroke, the final outcome is hypoxic-ischemic damage of brain tissues, hyperbaric oxygen therapy can significantly increase the oxygen pressure and blood oxygenation content, accelerate collateral circulation to protect neurons, repair the damaged microvessels, stimulate angiogenesis and neurogenesis, and accordingly, play neuroprotective role (Gill and Bell, 2004; Sanchez, 2013). Hydrogen has also been found play roles of anti-inflammation, anti-oxygenation and anti-apoptosis when a stroke occurs. Hydrogen sulfide (H~2~S) has always been considered as a toxic gas with its odor of rotten eggs, because it could play the cytotoxic role through inhibiting cytochrome C oxidase and mitochondrial respiration (Furne et al., 2001; Partlo et al., 2001). However, in recent years, accumulating evidences have suggesting that H~2~S is an another important gaseous signaling molecule in biological systems following nitric oxide (NO) and carbon monoxide and in central nervous system (CNS) (Wang, 2002; Li and Moore, 2008), a larger number of researches have shown that it has neuroprotective effects as neurotransmitter (Kimura and Kimura, 2004; Whiteman et al., 2004), and researchers hope to provide a new direction for the therapy of stroke through studying H~2~S. After the endogenous H~2~S was first found in the brain in the end of 20^th^ century (Warenycia et al., 1989), researchers gradually found that the production of H~2~S in CNS predominantly involve three particular enzymes: cystathionine-β-synthase (CBS), cystathionine-γ-lyase (CSE) and 3-mercaptopyruvate sulfurtransferase (3-MST), which could convert to H~2~S from L-cysteine (Cys) in combination with cysteine aminotransferase (CAT) (Kolluru et al., 2013; Jung and Jeong, 2014). That is to say, CSE primarily induce the production of H~2~S in cardiovascular system, while CBS mainly is responsible for producing H~2~S in the CNS (Qu et al., 2008; Kimura et al., 2012), and CBS uses Cys and homocysteine (Hcy) that have been known the risk factors for stroke and heart disease as substrates (Abe and Kimura, 1996; Chen et al., 2004; Singh et al., 2009). Interestingly, although there are amounting evidences showing that H~2~S participates in the regulation of neuronal function and signaling pathway, concerning the neuroprotective or neurotoxic effects of H~2~S still remains controversial. In our review, we will discuss the main mechanism and the possible role of H~2~S in stroke.
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Because of its toxicity, people have always thought that the concentration of H~2~S in animal tissues is very low for a long time. However, as what we have known, H~2~S could be produced endogenously, and further studies indicate that H~2~S could exist in mammalian tissues at very high concentration, up to 50--160 mM (Goodwin et al., 1989; Warenycia et al., 1989), which is dramatically higher than that in the peripheral blood (0--46 mM) (Zhao et al., 2003), suggesting that H~2~S may have some effects and show potential therapeutic value in some CNS diseases, including stroke, traumatic brain injury, Alzheimer\'s disease and Parkinson\'s disease.

Here, we give a brief description on the mechanisms of H~2~S in the CNS as follows (**[Figure 1](#F1){ref-type="fig"}**): (1) anti-oxidation: facing the oxidative stress injury after stroke occurring, H~2~S could promote the activation of cystine/glutamate antiporter and increase the intracellular concentrations of Cys that it is a kind of substrate for the generation of glutathione. In addition, in this process, γ-glutamyl-cysteine synthetase, a kind of rate-limiting enzyme, could also be activated by H~2~S and regulates the production of glutathione (Kimura and Kimura, 2004; Kimura et al., 2010), which is an important intracellular antioxidant. Thus, the intracellular levels of glutathione increases and could clear the reactive oxygen species (ROS) existing in the mitochondria to achieve the goal of protecting the neurons from oxidative stress injury. (2) Anti-inflammatory effects: the major sites that H~2~S plays the role of fighting inflammatory response are astrocytes and microglia (Seifert and Pennypacker, 2014), where H~2~S could inhibit the release of NO, tumor necrosis factor-α and the proinflammatory cytokine interleukin-1β, and decrease the activation of p38/c-Jun N-terminal kinase, conversely, increase the release of anti-inflammatory cytokines, for instance, interleukin-4/10. It is reported that SB 203580, a kind of p38 mitogen-activated protein kinase (MAPK) inhibitor, could mimic the anti-inflammatory effects, indicating that H~2~S may regulate the immune function by MAPK signaling pathway (Hu et al., 2007), but concrete mechanisms still need to be investigated. (3) Anti-apoptosis: a growing body of evidence points that H~2~S exerts its role of anti-apoptosis probably *via* mitochondrial apoptotic pathway, H~2~S could inhibit the caspase-3 signaling pathway mediated by ROS and calcium pathway activated by hydrogen peroxide (Liu et al., 2014), accordingly, prevent the apoptosis induced by oxygen glucose deprivation/reoxygenation (Luo et al., 2012, 2013). In addition, H~2~S could promote the nuclear translocation of nuclear factor kappa B (NF-κB), which activates the anti-apoptotic gene (Sen et al., 2012). (4) Facilitating long-term potentiation: It has always been demonstrated that H~2~S can facilitate hippocampal long-term potentiation *via* activating N-methyl-D-aspartic acid (NMDA) receptor (Kimura, 2002). Subsequently, researchers found that unlike carbon monoxide or NO, H~2~S promotes the accumulation of cyclic adenosine monophosphate rather than cyclic guanosine monophosphate (Kimura, 2000), and NMDA receptor activation induced by H~2~S could be inhibited by adenylate cyclase inhibitor (Kimura, 2002). (5) Regulating calcium concentration: H~2~S can activate calcium channel to increase calcium influx, whereas decrease the release of calcium stored in the cells, thus induce the production of calcium waves in primary cultures of astrocytes, and this process can be inhibited by calcium channel antagonist (Nagai et al., 2004). In addition, H~2~S has been known as an ATP sensitive potassium (K~ATP~) channel activator in secondary brain injury after stroke or other diseases, H~2~S could play its neuroprotection through mimicking K~ATP~ channel (Jiang et al., 2013). However, the problem of calcium overload cannot be ignored (O'Bryant et al., 2014). There are accumulating evidence that the neuroprotection or neurotoxicity of H~2~S depends on the concentration of it, which needs further investigations, including animals and clinical trials.
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As we have known, a large number of animal studies must be tested before clinical application for anything, H~2~S is no exception. In view of the toxicity and high solubility of H~2~S, it is even uncommon to inhale it directly; therefore, sodium hydrosulfide (NaHS, a H~2~S donor) is widely applied in animal studies concerning cerebral injury after stroke. At present, researchers gradually reach a consensus that the neuroprotection of H~2~S in stroke is dose-dependent, that is, the relatively low-dose of H~2~S in brain may play neuroprotective effect in stroke, whereas high concentration of H~2~S may cause neurotoxicity, suggesting that we must view H~2~S from a comprehensive perspective, and enhance its advantage, while avoid its disadvantage, to apply H~2~S in clinical treatment more effectually. In our review, we will show our analysis for animal studies about the role H~2~S in stroke (**[Table 1](#T1){ref-type="table"}**).
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The neuroprotective and neurotoxic effects of hydrogen sulfide (H~2~S) in stroke
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The neuroprotection of H~2~S is exhibited as follows: (1) Li et al. (2011) reported that H~2~S, whose concentration is 0.1 mM, has neuroprotective effects by protecting hippocampal neurons, improving the deficiency of learning and memory, and increasing synaptic plasticity, decreasing the brain edema around pyramidal neurons and their nuclear shrink in a rat brain model of stroke. (2) In a rat model of reversible occlusion of the right middle cerebral artery, H~2~S was found to reduce infarct volume through long-term hypothermia and the decrease of the expression of NF-κB, thus protecting the brain against hypoxic injury due to stroke (Florian et al., 2008). (3) After stroke, the endogenous concentration of H~2~S increases at 12 hours and decreases at 24 hours. In addition, if pretreated by NaHS at a relatively low dose (25 mmol/kg), the brain injury could be attenuated at 7 days after stroke (Ren et al., 2010). NaHS is also reported to protect brain against oxygen glucose deprivation injury (Tay et al., 2010). (4) By stimulating the phosphorylation of protein kinase B and extracellular signal regulated kinases, up-regulating vascular endothelial growth factor and angiopoietin-1 expression, H~2~S could promote angiogenesis around the infarct area, and show better functional outcomes in a rat model of middle cerebral artery occlusion (MCAO) (Jang et al., 2014). (5) H~2~S has anti-oxidative, anti-inflammatory, and anti-apoptotic effects in stroke; and in cerebral ischemia/reperfusion injury, it is also reported H~2~S could increase the superoxide dismutase activity, anti-inflammatory interlukin-10 and anti-apoptotic protein Bcl-2, accordingly, play the role of neuroprotection (Yin et al., 2013). In addition, H~2~S, or its donor, can reduce the infarct size and decrease the blood brain barrier damage in a model of cerebral ischemia-reperfusion injury (Gheibi et al., 2014).

However, different models, administration paradigms and concentration of H~2~S may cause different results, even get the opposite conclusion: (1) Using the same model of MCAO, Qu et al. (2006) found that if the H~2~S concentration is raised to 0.18 mM, the infarct volume will increase, instead of decrease, and this process can be ameliorated by H~2~S synthesis inhibitors or NMDA receptor channel inhibitors, suggesting that H~2~S has different effects on brain in different dose-concentration. (2) The concentration of H~2~S increases in the cortex, and reach the peak at 12 hours after cerebral ischemia, then it will decrease (Ren et al., 2010). A recent research showed that H~2~S, at a high dose level, can cause cell death in cerebral cortex based on the model of permanent MCAO, and in this process, the infarct volume can be reduced by the inhibitors of H~2~S synthesis enzymes, on the contrary, decreased by the administration of NaHS (Qu et al., 2006). (3) In addition, when the concentration of NaHS is below 200 μM, the apoptosis can be induced, while the concentration is higher than 200 μM, NaHS will induce necrosis and cause brain damage (Cheung et al., 2007).

In general, the neuroprotective effect of H~2~S in stroke is concentration-dependent, only a relatively low dose of H~2~S can yield beneficial effect. However, there is a point we have to say, the most of research on H~2~S at present mainly focus on ischemic stroke, while study concerning the hemorrhagic stroke is very few, which need us to do more research to reveal the role of H~2~S in entire stroke.
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==============================

At present, there is no direct clinical studies about neuroprotection of H~2~S being reported. However, the plasma H~2~S level has been reported to be related to long-term clinical outcome in stroke patients. A clinical study involving 36 patients showed that high plasma Cys levels on admission and before treatment tend to poor clinical outcome when assessed at 3 months after stroke, and the patients who have early stroke deterioration are usually correlated significantly with high plasma level of Cys (Wong et al., 2006), suggesting that H~2~S may be indirectly responsible for this effect. Furthermore, as accumulating evidence shows that hyper Hcy is a risk factor for stroke (Abbate et al., 2003; Kim et al., 2003; Hassan et al., 2004), Parnetti et al. (2004) found that the concentration of Hcy increased in all stroke subtypes in a case-control study including 313 participants (161 patients and 152 controls), indicating that Hcy may be used as a marker for the clinical outcome of stroke as well. However, the definite relationship between hyper Hcy and stroke has not been found (Fallon et al., 2001), and several meta-analyses have not reached an agreement (Homocysteine Studies Collaboration, 2002; Fallon and Ben-Shlomo, 2003). Above all, although there is no direct evidence indicating that H~2~S has neuroprotective effect in clinical trials, the close touch with brain injury caused by stroke is no doubt, and needs us to make great efforts to study.

N[EUROTOXICITY OF]{.smallcaps} H~2~S {#sec1-5}
====================================

As what we have mentioned above, the high dose-concentration of H~2~S can cause systemic toxicity reacts (Nakata et al., 2015; Wu et al., 2015), especially neurotoxic effect, because it inhibits cytochrome C oxidase and mitochondrial respiration. The CNS is sensitive to hypoxia, H~2~S poisoning can lead to respiratory paralysis rapidly and cause a series of nerve dysfunction, including brain edema, disturbance of consciousness, and others. Therefore, the following strategies are extremely important, including oxygen uptake, keeping the airway open, and symptomatic and supportive treatments.

C[ONCLUSION]{.smallcaps} {#sec1-6}
========================

Although H~2~S is known as a toxic substance, increasing evidences have indicated that H~2~S plays an important role of neuroprotection in stroke, while its neurotoxicity cannot be neglected. So, we need to view H~2~S in the point of dialectics, and we believe that further research on H~2~S, including animal studies and clinical studies, may provide a new insight into the treatment of stroke and other CNS diseases, such as traumatic brain injury and neurodegenerative diseases.
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